Tempest Therapeutics
Development-stage biotechnology company.
HQ location
San Francisco, United States
Website
Launch date
Employees
Market cap
$25.4m
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| investor investor investor investor investor investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor investor investor investor investor investor investor investor | €0.0 | round | |
| investor investor | €0.0 | round | |
* | N/A | $4.6m | Post IPO Equity |
| Total Funding | 000k | ||
F-Prime(exited)
Versant Ventures(exited)
Eight Roads Ventures(exited)
Foresite Capital(exited)
Lilly Asia Ventures(exited)
Quan Capital(exited)
Millendo Therapeutics(exited)
Rock Springs Capital(exited)
Monashee Investment Management(exited)
LYFE Capital(exited)
Maven Investment Partners(exited)
NEA(exited)
EcoR1 Capital(exited)
Quan Capital(exited)
| USD | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article, Equity research estimates
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.